MicrocapLens @MicrocapLens

In Feb 2026, Galloway Capital disclosed a 5.02% stake in GSI Technology, Inc. $GSIT , calling the stock significantly undervalued. It cited weak investor communication and urged steps to unlock shareholder value while seeking board engagement.

With tensions in the middle east increasing,  activist investors are focusing intensely on the oil and gas sector.   Recent successes for activists include Barry Hugghins defeating the board of Bri-Chem at the September 2025 meeting.

Steamboat’s Parsa Kiai opposes $PRTH CEO’s take-private offer at $6–$6.15/share, calling it <5x ’26E EPS (~$1.30). With >90% recurring revenue and strong FCF, he sees intrinsic value at $15–$20/share. PRTH isn’t flashy fintech—it’s payments plumbing that works if execution.

Greenwood Investors outlines its constructive engagement with $JACK , backing new CEO’s return-to-basics plan. Following a cooperation agreement adding Alan Smolinisky & Mark King to the board, Greenwood sees a turnaround path through ops excellence, digital/marketing focus

In Feb 2026, Commonwealth Asset Management blasted Innventure’s $INV weak post-de-SPAC performance, high overhead, and repeated dilution.It urged sharp cost cuts, focus on Accelsius, board/management changes — and warned further action may follow.

In Feb 2026, Fund 1 Investments (9.96%) in Funko Inc. $FNKO said it plans to engage with the board & management to push shareholder value initiatives — including a potential strategic alternatives process that could involve a sale.

In Feb 2026, Commonwealth Asset Management blasted Innventure’s $INV weak post-de-SPAC performance, high overhead, and repeated dilution. It urged sharp cost cuts, focus on Accelsius, board/management changes — and warned further action may follow.

In Feb 2026, Fund 1 Investments (9.96%) in Funko Inc. $FNKO said it plans to engage with the board & management to push shareholder value initiatives — including a potential strategic alternatives process that could involve a sale.

Vaso Corp (OTCMKTS: VASO) Healthcare-IT/micro-services company with ~$25M cash (no material debt) → negative enterprise value. Revenue doubled recently via EU deals, yet still deeply discounted; perfect for activist pressure on buybacks, special dividends, or strategic sale.

Identiv, Inc. (NASDAQ: INVE) RFID/security tech firm criticized for costly business expansion that destroyed value. Trading at a material discount to potential sale/break-up value; better served as an acquisition target than standalone.

ESSA Pharma Inc. (EPIX) Clinical-stage biotech trading at a ~35% discount to cash & short-term investments (no debt burden). Operations have stalled; liquidation would immediately return cash to shareholders. oleus Capital Management is actively pushing for full liquidation.

Charles & Colvard Ltd. (NASDAQ: CTHR) Fine jewelry company facing trajectory concerns; trading at extreme discounts with minimal coverage. Activism aims to overhaul board/strategy in a tiny, overlooked name. Current activism: Pham Duc Hoang and Riverstyx Fund filed Schedule 13D

Edesa Biotech, Inc-EDSA has shown an extraordinary one-month gain of approximately +507.6% (from around $1.05 to $6.38 in the referenced data period ending around mid-March 2026). This places it at or near the top of monthly gainers lists across major U.S. exchanges.

BW (Babcock & Wilcox Enterprises) — Extremely strong longer-term (e.g., +1432% over 52 weeks), with continued strength into 2026

Small-caps kicked off 2026 strongly, leading market gains in the first few weeks and months. For instance, the Russell 2000 outperformed large-cap indices like the S&P 500 in early January, with reports of the longest consecutive outperformance streak since 1996.

Scilex Holding Company(SCLX) The pain management biotech has seen ongoing short interest growth (up ~26% in February to ~2.9% of float) alongside developments like a $20 million strategic investment in quantum scan tech and updates on meme coin distributions tied to partnerships.

SUNation Energy(SUNE) This solar and energy services company recently surged over 135% in a single week after announcing a key financing agreement with Palmetto to support residential solar deployments starting in 2026, pushing shares to 9-month highs amid debt reduction efforts.

Actelis Networks (ASNS): Surged dramatically (up 120%+ intraday, with reports of 189%+ moves in some sessions). Traders reacted to a newly announced Caltrans order (California transportation-related), sparking momentum in this networking/infrastructure micro-cap.

High one-year returns in some micro/small-caps (e.g., over 1000% in select names like AXT Inc or Hycroft Mining) highlight speculative upside, though volatility is extreme.

The Russell Microcap Index has led gains significantly in early 2026. It posted strong returns in January (around 5-6% in some reports) and continued momentum into February, with year-to-date figures showing microcaps outperforming broader indices.Note:Microcap is highly volatile